CM serves or has served on advisory panels for ActoBio Therapeutics, AstraZeneca, Avotres, Boehringer Ingelheim, Eli Lilly, Imcyse, Insulet, Merck Sharp and Dohme, Mannkind, Medtronic, Novo Nordisk, Novartis, Pfizer, Roche, Sandoz, Sanofi, Vertex, and Zealand Pharma; serves or has served on speakers bureaus for AstraZeneca, Boehringer Ingelheim, Eli Lilly, Novo Nordisk, Novartis, and Sanofi; is president of the European Association for the Study of Diabetes; and has received research funding, paid to her institution, from ActoBio Therapeutics, Imcyse, Medtronic, Novo Nordisk, and Sanofi.